Literature DB >> 28539206

Prediabetes is not a risk factor for subclinical coronary atherosclerosis.

Gyung-Min Park1, Young-Rak Cho2, Seung-Whan Lee3, Sung-Cheol Yun4, Ki-Bum Won1, Soe Hee Ann1, Yong-Giun Kim1, Shin-Jae Kim1, Jae-Hyung Roh5, Young-Hak Kim6, Dong Hyun Yang7, Joon-Won Kang7, Tae-Hwan Lim7, Chang Hee Jung8, Eun Hee Koh8, Woo Je Lee8, Min-Seon Kim8, Ki-Up Lee8, Joong-Yeol Park8, Hong-Kyu Kim9, Jaewon Choe9, Sang-Gon Lee1.   

Abstract

BACKGROUND: There are limited data regarding the influence of glycemic status on the risk of subclinical coronary atherosclerosis on coronary computed tomographic angiography (CCTA) in asymptomatic individuals.
METHODS: We analyzed 6434 asymptomatic individuals who underwent CCTA. The degree and extent of subclinical coronary atherosclerosis were assessed by CCTA, and ≥50% diameter stenosis was defined as significant. Of study participants, 2197 (34.1%), 3122 (48.5%), and 1115 (17.3%) were categorized as normal, prediabetic and diabetic individuals, respectively.
RESULTS: Compared with normal individuals, there were no statistically differences in the adjusted odds ratios of prediabetic individuals for significant coronary artery stenosis (0.98, 95% confidence interval [CI] 0.80-1.22, p=0.888), any plaque (0.96, 95% CI 0.86-1.07, p=0.483), calcified plaque (0.90, 95% CI 0.79-1.01, p=0.080), non-calcified plaque (1.02, 95% CI 0.88-1.17, p=0.803), and mixed plaque (1.00, 95% CI 0.82-1.22, p=0.983). However, adjusted odds ratios for significant coronary artery stenosis (1.71, 95% CI 1.34-2.19, p<0.001), any plaque (1.45, 95% CI 1.26-1.68, p<0.001), calcified plaque (1.35, 95% CI 1.15-1.57, p<0.001), non-calcified plaque (1.33, 95% CI 1.11-1.59, p=0.002), and mixed plaque (1.64, 95% CI 1.30-2.07, p<0.001) of diabetic individuals were significantly higher than those of the normal individuals.
CONCLUSION: In asymptomatic individuals, diabetic individuals had a higher risk for subclinical coronary atherosclerosis, but prediabetic individuals were not associated with an increased risk of subclinical coronary atherosclerosis.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; Coronary artery disease; Diabetes; Prediabetes

Mesh:

Substances:

Year:  2017        PMID: 28539206     DOI: 10.1016/j.ijcard.2017.05.073

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  3 in total

1.  Evaluation of the impact of glycemic status on the progression of coronary artery calcification in asymptomatic individuals.

Authors:  Ki-Bum Won; Donghee Han; Ji Hyun Lee; Sang-Eun Lee; Ji Min Sung; Su-Yeon Choi; Eun Ju Chun; Sung Hak Park; Hae-Won Han; Jidong Sung; Hae Ok Jung; Hyuk-Jae Chang
Journal:  Cardiovasc Diabetol       Date:  2018-01-04       Impact factor: 9.951

2.  Characteristics of atheromatosis in the prediabetes stage: a cross-sectional investigation of the ILERVAS project.

Authors:  Enric Sánchez; Àngels Betriu; Carolina López-Cano; Marta Hernández; Elvira Fernández; Francisco Purroy; Marcelino Bermúdez-López; Cristina Farràs-Sallés; Silvia Barril; Reinald Pamplona; Ferran Rius; Cristina Hernández; Rafael Simó; Albert Lecube
Journal:  Cardiovasc Diabetol       Date:  2019-11-15       Impact factor: 9.951

3.  Homocysteine is not a risk factor for subclinical coronary atherosclerosis in asymptomatic individuals.

Authors:  Sangwoo Park; Gyung-Min Park; Jinhee Ha; Young-Rak Cho; Jae-Hyung Roh; Eun Ji Park; Yujin Yang; Ki-Bum Won; Soe Hee Ann; Yong-Giun Kim; Shin-Jae Kim; Sang-Gon Lee; Dong Hyun Yang; Joon-Won Kang; Tae-Hwan Lim; Hong-Kyu Kim; Jaewon Choe; Seung-Whan Lee; Young-Hak Kim
Journal:  PLoS One       Date:  2020-04-08       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.